Bionano Genomics (BNGO) Short Interest Ratio & Short Volume $3.85 -0.05 (-1.28%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bionano Genomics Short Interest DataBionano Genomics (BNGO) has a short interest of 332,600 shares, representing 9.93% of the float (the number of shares available for trading by the public). This marks a -19.37% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 160,260 shares to cover all short positions.Current Short Interest332,600 sharesPrevious Short Interest412,500 sharesChange Vs. Previous Month-19.37%Dollar Volume Sold Short$1.00 millionShort Interest Ratio3.2 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares4,680,000 sharesFloat Size3,350,000 sharesShort Percent of Float9.93%Today's Trading Volume104,833 sharesAverage Trading Volume160,260 sharesToday's Volume Vs. Average65% Short Selling Bionano Genomics? Sign up to receive the latest short interest report for Bionano Genomics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBNGO Short Interest Over TimeBNGO Days to Cover Over TimeBNGO Percentage of Float Shorted Over Time Bionano Genomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025332,600 shares $1.00 million -19.4%9.9%3.2 $3.01 7/15/2025412,500 shares $1.39 million -17.2%12.3%4.1 $3.38 6/30/2025498,100 shares $1.63 million -9.3%14.9%3.7 $3.28 6/15/2025549,000 shares $2.00 million -10.2%16.4%4 $3.65 5/31/2025611,100 shares $2.24 million +6.4%18.2%4.5 $3.67 5/15/2025574,300 shares $2.26 million +18.1%17.1%3.9 $3.93 4/30/2025486,200 shares $1.94 million -18.6%15.7%3.5 $3.99 4/15/2025597,400 shares $2.67 million +1.6%19.3%3.1 $4.47 3/31/2025587,800 shares $1.64 million +15.7%19.6%3.3 $2.79 3/15/2025508,200 shares $1.76 million +0.3%18.7%2.4 $3.47 Get the Latest News and Ratings for BNGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bionano Genomics and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025506,700 shares $2.11 million +7.6%18.6%2.4 $4.16 2/15/2025471,100 shares $2.71 million +6.1%17.3%2.3 $5.76 1/31/2025443,900 shares $2.30 million +30.0%19.1%2.4 $5.19 1/15/2025341,500 shares $4.07 million -98.1%14.7%2.4 $11.92 12/31/202417,650,000 shares $5.09 million +11.4%12.7%2.6 $0.29 12/15/202415,840,000 shares $3.80 million +25.1%15.6%5.5 $0.24 11/30/202412,660,000 shares $3.29 million +4.5%12.5%4.8 $0.26 11/15/202412,110,000 shares $2.98 million +23.2%12.0%5.2 $0.25 10/31/20249,830,000 shares $2.85 million +28.2%10.3%4.9 $0.29 10/15/20247,670,000 shares $2.53 million +26.4%9.0%4.2 $0.33 9/30/20246,070,000 shares $2.76 million +45.9%8.8%3.9 $0.45 9/15/20244,160,000 shares $1.79 million +13.0%6.1%2.4 $0.43 8/31/20243,680,000 shares $1.80 million -13.0%5.4%2.1 $0.49 8/15/20244,230,000 shares $2.19 million -5.4%6.2%2.4 $0.52 7/31/20244,470,000 shares $2.87 million -7.1%6.5%2.7 $0.64 7/15/20244,810,000 shares $3.02 million -16.6%7.0%3.4 $0.63 6/30/20245,770,000 shares $3.91 million +9.9%8.4%4.1 $0.68 6/15/20245,250,000 shares $4.36 million +11.9%7.7%4 $0.83 5/31/20244,690,000 shares $4.54 million -5.8%6.9%3.6 $0.97 5/15/20244,980,000 shares $5.73 million -3.3%7.5%3.6 $1.15 4/30/20245,150,000 shares $4.55 million -3.9%7.8%3.6 $0.88 4/15/20245,360,000 shares $4.66 million +1.7%8.9%3.5 $0.87 3/31/20245,270,000 shares $5.85 million -3.7%9.8%3.2 $1.11 3/15/20245,470,000 shares $5.52 million +4.6%10.2%3.1 $1.01 2/29/20245,230,000 shares $6.54 million -7.1%9.7%2.8 $1.25 2/15/20245,630,000 shares $7.15 million +0.5%14.8%3.1 $1.27 1/31/20245,600,000 shares $6.61 million +14.5%14.7%3.1 $1.18 1/15/20244,890,000 shares $6.65 million -3.4%12.8%2.9 $1.36 12/31/20235,060,000 shares $9.56 million -1.6%13.3%3.4 $1.89 12/15/20235,140,000 shares $7.71 million -7.2%13.5%4.1 $1.50INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)Right now, we’re witnessing a monumental shift in the world.Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. 11/30/20235,540,000 shares $8.81 million -21.8%14.5%5.6 $1.59 11/15/20237,080,000 shares $9.70 million +7.1%18.6%7.8 $1.37 10/31/20236,610,000 shares $9.12 million +15.6%19.1%7.6 $1.38 10/15/20235,720,000 shares $12.70 million +13.0%16.6%6.3 $2.22 9/30/20235,060,000 shares $15.33 million -0.8%16.9%5.8 $3.03 9/15/20235,100,000 shares $16.58 million +6.9%17.0%5 $3.25 8/31/20234,770,000 shares $18.41 million +15.2%15.7%4.3 $3.86 8/15/20234,140,000 shares $13.83 million -8.4%13.6%3.7 $3.34 7/31/20234,520,000 shares $26.56 million -89.7%N/A4.2 $5.88 7/15/202343,910,000 shares $28.45 million -8.8%N/A4.4 $0.65 6/30/202348,120,000 shares $29.35 million -19.5%N/A4.6 $0.61 6/15/202359,800,000 shares $44.22 million -4.5%N/A6.5 $0.74 5/31/202362,620,000 shares $43.33 million -2.8%N/A7.7 $0.69 5/15/202364,400,000 shares $42.67 million +3.4%N/A8.7 $0.66 4/30/202362,260,000 shares $42.83 million -1.0%N/A8.7 $0.69 4/15/202362,890,000 shares $68.55 million +8.0%N/A8.8 $1.09 3/31/202358,260,000 shares $64.67 million +6.4%N/A9.5 $1.11 3/15/202354,780,000 shares $65.74 million -5.0%N/A8.5 $1.20 2/28/202357,650,000 shares $77.25 million +17.2%N/A8.1 $1.34 2/15/202349,200,000 shares $80.20 million -5.9%N/A6.9 $1.63 1/31/202352,260,000 shares $94.59 million -1.8%N/A7.1 $1.81 1/15/202353,220,000 shares $96.33 million +2.8%N/A6.9 $1.81 12/30/202251,790,000 shares $75.61 million +6.2%N/A7 $1.46 12/15/202248,760,000 shares $94.11 million +15.6%N/A6.5 $1.93 11/30/202242,200,000 shares $84.82 million -1.3%N/A6.1 $2.01 11/15/202242,740,000 shares $120.10 million -6.6%N/A6.5 $2.81 10/31/202245,770,000 shares $107.10 million -2.1%N/A5.5 $2.34 10/15/202246,730,000 shares $95.80 million +8.4%N/A5.7 $2.05 9/30/202243,100,000 shares $78.87 million +5.2%N/A5.4 $1.83 9/15/202240,990,000 shares $96.33 million +8.4%N/A5.1 $2.35 8/31/202237,830,000 shares $93.82 million -3.4%N/A4.7 $2.48 8/15/202239,140,000 shares $140.90 million -14.2%N/A4.8 $3.60 7/31/202245,640,000 shares $84.89 million +3.3%N/A7.2 $1.86 7/15/202244,170,000 shares $68.02 million -0.3%N/A7.1 $1.54 6/30/202244,300,000 shares $61.13 million +16.4%N/A7 $1.38 6/15/202238,050,000 shares $54.41 million -1.7%N/A5.8 $1.43 5/31/202238,710,000 shares $66.97 million -3.1%N/A5.7 $1.73 5/15/202239,930,000 shares $64.69 million -11.7%N/A5.5 $1.62 4/30/202245,210,000 shares $73.69 million +2.4%N/A6.2 $1.63 4/15/202244,170,000 shares $91.43 million +13.9%N/A5.7 $2.07 3/31/202238,790,000 shares $100.08 million +1.0%N/A4.8 $2.58 3/15/202238,390,000 shares $67.18 million -0.5%N/A4.6 $1.75 2/28/202238,580,000 shares $82.56 million +0.6%N/A4.6 $2.14 2/15/202238,370,000 shares $83.65 million +1.8%N/A4.5 $2.18 1/31/202237,680,000 shares $83.65 million +0.2%N/A4.3 $2.22 1/15/202237,600,000 shares $95.88 million -7.2%N/A4.1 $2.55 12/31/202140,520,000 shares $121.15 million -2.3%N/A4.7 $2.99 12/15/202141,480,000 shares $141.86 million +3.3%N/A5 $3.42 11/30/202140,170,000 shares $157.06 million +7.1%N/A4.7 $3.91 11/15/202137,500,000 shares $187.50 million -1.4%N/A4.5 $5.00INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)Right now, we’re witnessing a monumental shift in the world.Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. 10/29/202138,020,000 shares $193.14 million -9.5%N/A4.7 $5.08 10/15/202142,030,000 shares $216.87 million +4.2%15.1%5.5 $5.16 9/30/202140,330,000 shares $221.82 million -9.4%14.5%4.9 $5.50 9/15/202144,490,000 shares $234.91 million -2.0%16.0%4.5 $5.28 8/31/202145,390,000 shares $264.62 million No Change16.3%4.2 $5.83 8/13/202145,390,000 shares $258.27 million +8.6%16.3%3.1 $5.69 7/30/202141,810,000 shares $247.93 million -6.9%15.0%2.3 $5.93 7/15/202144,920,000 shares $262.33 million -13.8%16.2%2.2 $5.84 6/30/202152,100,000 shares $381.89 million +36.2%18.8%2.2 $7.33 6/15/202138,260,000 shares $281.98 million -0.7%13.8%1.6 $7.37 5/28/202138,520,000 shares $237.67 million +5.4%13.9%1.6 $6.17 5/14/202136,550,000 shares $161.19 million +15.9%N/A1.4 $4.41 4/30/202131,530,000 shares $208.41 million +8.7%N/A1.1 $6.61 4/15/202129,020,000 shares $186.45 million +1.5%N/A0.8 $6.43 3/31/202128,580,000 shares $220.64 million +20.2%N/A0.6 $7.72 3/15/202123,780,000 shares $223.06 million +8.5%N/A0.3 $9.38 2/26/202121,920,000 shares $219.64 million +15.1%N/A0.3 $10.02 2/12/202119,050,000 shares $222.89 million -28.7%N/A0.2 $11.70 1/29/202126,700,000 shares $281.15 million +4.8%N/A0.3 $10.53 1/15/202125,470,000 shares $177.02 million +63.1%N/A0.4 $6.95 12/31/202015,620,000 shares $32.80 million +84.2%N/A0.3 $2.10 12/15/20208,480,000 shares $4.24 million +9.6%N/A1.3 $0.50 11/30/20207,740,000 shares $3.78 million +5.5%N/A1.5 $0.49 11/15/20207,340,000 shares $3.81 million +16.7%N/A1.3 $0.52 10/30/20206,290,000 shares $3.24 million +7.9%N/A1 $0.52 10/15/20205,830,000 shares $3.44 million +0.5%N/A0.6 $0.59 9/30/20205,800,000 shares $3.77 million +6.8%N/A0.3 $0.65 9/15/20205,430,000 shares $3.25 million +7.5%N/A0.2 $0.60 8/31/20205,050,000 shares $3.07 million +16.9%N/A0.2 $0.61 BNGO Short Interest - Frequently Asked Questions What is Bionano Genomics' current short interest? Short interest is the volume of Bionano Genomics shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 332,600 shares of BNGO short. 9.93% of Bionano Genomics' shares are currently sold short. Learn More on Bionano Genomics' current short interest. What is a good short interest ratio for Bionano Genomics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNGO shares currently have a short interest ratio of 3.0. Learn More on Bionano Genomics's short interest ratio. What is a good short interest percentage for Bionano Genomics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.93% of Bionano Genomics' floating shares are currently sold short. Is Bionano Genomics' short interest increasing or decreasing? Bionano Genomics saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 332,600 shares, a drop of 19.4% from the previous total of 412,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bionano Genomics' float size? Bionano Genomics currently has issued a total of 4,680,000 shares. Some of Bionano Genomics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bionano Genomics currently has a public float of 3,350,000 shares. How does Bionano Genomics' short interest compare to its competitors? 9.93% of Bionano Genomics' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Bionano Genomics: Autoscope Technologies Co. (0.05%), Data I/O Corporation (0.32%), ClearSign Technologies Corporation (0.40%), MultiSensor AI Holdings, Inc. (1.48%), Precipio, Inc. (0.71%), Astrotech Corporation (0.23%), Talis Biomedical Co. (0.55%), Schmitt Industries, Inc. (0.00%), Telesis Bio, Inc. (0.02%), ThermoGenesis Holdings, Inc. (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Bionano Genomics stock? Short selling BNGO is an investing strategy that aims to generate trading profit from Bionano Genomics as its price is falling. BNGO shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bionano Genomics? A short squeeze for Bionano Genomics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNGO, which in turn drives the price of the stock up even further. How often is Bionano Genomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNGO, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies AATC Short Interest Data DAIO Short Interest Data CLIR Short Interest Data MSAI Short Interest Data PRPO Short Interest Data ASTC Short Interest Data TLIS Short Interest Data SMIT Short Interest Data TBIO Short Interest Data THMO Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNGO) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access